Long-term safety and efficacy of apomorphine infusion in Parkinson's disease (PD) patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study

被引：0
|
作者：
Katzenschlager, R.
Poewe, W.
Rascol, O. [1 ]
Trenkwalder, C. [2 ]
Deuschl, G. [3 ]
Chaudhuri, R. [4 ]
Henriksen, T. [5 ]
Van Laar, T. [6 ]
Lockhart, D. [7 ]
Lees, A. [8 ]
机构：
[1] Univ Toulouse, Dept Neurosci & Clin Pharmacol, Toulouse, France
[2] Paracelsus Elena Klin, Kassel, Germany
[3] Univ Kiel, Dept Neurol, Kiel, Germany
[4] Kings Coll Hosp NHS Fdn Trust, Natl Parkinson Fdn Int Ctr Excellence, London, England
[5] Univ Hosp Bispebjerg, Movement Disorder Clin, Copenhagen, Denmark
[6] Univ Med Ctr Groningen, Neurol, Groningen, Netherlands
[7] Britannia Pharmaceut, Reading, Berks, England
[8] Natl Hosp Neurol & Neurosurg, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR2058
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [41] Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study
    Salloway, Stephen
    Marshall, Gad A.
    Lu, Ming
    Brashear, H. Robert
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (13) : 1231 - 1243
  • [42] An open-label investigation of lamotrigine in Parkinson's patients with motor fluctuations
    Reider, CR
    Rienerth, JED
    Hubble, JP
    Paulson, GW
    NEUROLOGY, 1998, 50 (04) : A279 - A279
  • [43] Long-Term Safety and Efficacy of Foscarbidopa/Foslevodopa in Patients with Advanced Parkinson's disease (PD): Results from an Ongoing Phase 3 Open-Label Extension with Up to 1 Year Follow-Up
    Hauser, R.
    Fung, V.
    Kimber, T.
    Klos, K.
    Facheris, M.
    Jeong, A.
    Jia, J.
    Spiegel, A.
    Soileau, M.
    MOVEMENT DISORDERS, 2024, 39 : S317 - S318
  • [44] A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
    Camporeale, Angelo
    Kudrow, David
    Sides, Ryan
    Wang, Shufang
    Van Dycke, Annelies
    Selzler, Katherine J.
    Stauffer, Virginia L.
    BMC NEUROLOGY, 2018, 18
  • [45] A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
    Angelo Camporeale
    David Kudrow
    Ryan Sides
    Shufang Wang
    Annelies Van Dycke
    Katherine J. Selzler
    Virginia L. Stauffer
    BMC Neurology, 18
  • [46] First results for the BeyoND study: A phase 2b, international, open-label study evaluating long-term safety of ND0612 in patients with Parkinson's disease experiencing motor complications
    Poewe, W.
    Stocchi, F.
    Giladi, N.
    Adar, L.
    Rosenfeld, O.
    Oren, S.
    Olanow, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 63 - 63
  • [47] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
    Ferrante, M.
    Panes, J.
    Baert, F.
    Louis, E.
    Kaser, A.
    Gustafson, D.
    Hall, D.
    Boecher, W. O.
    Herichova, I.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G.
    GUT, 2019, 68 : A64 - A64
  • [48] LONG-TERM SAFETY AND TOLERABILITY OF PRIDOPIDINE IN PATIENTS WITH HUNTINGTON'S DISEASE (HD): RESULTS OF THE MERMAIHD STUDY OPEN-LABEL EXTENSION
    Squitieri, F.
    Landwehrmeyer, B.
    Reilmann, R.
    Rosser, A.
    Garcia de Yebenes, J.
    Prang, A.
    Ivkovic, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A56 - A57
  • [49] LONG-TERM PULMONARY SAFETY OF INHALED LEVODOPA IN PARKINSON'S DISEASE SUBJECTS WITH MOTOR FLUCTUATIONS: INTERIM RESULTS OF A PHASE 3 STUDY
    Grosset, D.
    Dhall, R.
    Gurevich, T.
    Kassubek, J.
    Poewe, W.
    Rascol, O.
    Rudzinska, M.
    Cormier, J.
    Sedkov, A.
    Oh, C.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E83 - E83
  • [50] Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
    Katzenschlager, Regina
    Poewe, Werner
    Rascol, Olivier
    Trenkwalder, Claudia
    Deuschl, Gunther
    Chaudhuri, K. Ray
    Henriksen, Tove
    van Laar, Teus
    Spivey, Kevin
    Vel, Senthil
    Staines, Harry
    Lees, Andrew
    LANCET NEUROLOGY, 2018, 17 (09): : 749 - 759
12345